IPO Timeline Raw facts
Company Overview
| Stock Name | Xunfeihealth |
|---|---|
| Stock Code | 02506 |
| Company Full Name | Xunfei Healthcare Technology Co., Ltd. |
| Industry | 軟件服務 |
| Principal Activities | 公司是一家人工智能賦能的醫療解決方案提供商。 |
| Listing Date | 2024-12-30 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市西城區廣安門內大街167號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.iflyhealth.com/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 82.80 / shares |
| Offer Price Range | Final offer price only, no range |
| Lot Size | 50 shares |
| Entry Threshold | HK$ 4,140 |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | 7,035,550 shares |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | No |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 47.5% |
| Clawback Tiers | To be extracted |
| Reallocation Option | No |
| Total Global Offering Size | HK$ 582,543,540 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 50 | HK$ 4,140 |
| 2 lots | 100 | HK$ 8,280 |
| 3 lots | 150 | HK$ 12,420 |
| 4 lots | 200 | HK$ 16,560 |
| 5 lots | 250 | HK$ 20,700 |
| 6 lots | 300 | HK$ 24,840 |
| 7 lots | 350 | HK$ 28,980 |
| 8 lots | 400 | HK$ 33,120 |
| 9 lots | 450 | HK$ 37,260 |
| 10 lots | 500 | HK$ 41,400 |
| 12 lots | 600 | HK$ 49,680 |
| 14 lots | 700 | HK$ 57,960 |
| 16 lots | 800 | HK$ 66,240 |
| 18 lots | 900 | HK$ 74,520 |
| 20 lots | 1,000 | HK$ 82,800 |
| 30 lots | 1,500 | HK$ 124,200 |
| 40 lots | 2,000 | HK$ 165,600 |
| 50 lots | 2,500 | HK$ 207,000 |
| 60 lots | 3,000 | HK$ 248,400 |
| 70 lots | 3,500 | HK$ 289,800 |
| 80 lots | 4,000 | HK$ 331,200 |
| 90 lots | 4,500 | HK$ 372,600 |
| 100 lots | 5,000 | HK$ 414,000 |
| 120 lots | 6,000 | HK$ 496,800 |
| 140 lots | 7,000 | HK$ 579,600 |
| 160 lots | 8,000 | HK$ 662,400 |
| 180 lots | 9,000 | HK$ 745,200 |
| 200 lots | 10,000 | HK$ 828,000 |
| 400 lots | 20,000 | HK$ 1,656,000 |
| 600 lots | 30,000 | HK$ 2,484,000 |
| 800 lots | 40,000 | HK$ 3,312,000 |
| 1,000 lots | 50,000 | HK$ 4,140,000 |
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1,400 lots | 70,000 | HK$ 5,796,000 |
| 1,600 lots | 80,000 | HK$ 6,624,000 |
| 1,800 lots | 90,000 | HK$ 7,452,000 |
| 2,000 lots | 100,000 | HK$ 8,280,000 |
| 4,000 lots | 200,000 | HK$ 16,560,000 |
| 7,036 lots | 351,800 | HK$ 29,129,040 |
Stock Connect Inclusion Analysis
| Avg Daily HK Mkt Cap | HK$ 5.73B |
|---|---|
| Analysis Result | Already included in Stock Connect (both) |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | RMB 142.5 million |
| Listing Expenses | ~HK$ 75,400,000 |
| Listing Expenses / Funds Raised | ~12.94% |
| Total Pre-IPO Investment | To be extracted |
| First Day Close | HK$ 87.0 |
|---|---|
| First Day Open | HK$ 89.75 |
| First Day Change | 5.07% |
| First Day Volume | 520446.0 |
| First Day Turnover | 45709400.0 |
| Use of Proceeds | 1、約32.4%(即164.0百萬港元)將用于投資研發,以不斷加強公司的核心能力;
2、約26.6%(即135.0百萬港元)將用于通過升級現有產品及開發新產品進一步豐富公司的產品及服務;
3、約24.7%(即125.1百萬港元)將用于加強商業化能力并擴展公司的服務網絡;
4、約6.4%(即32.3百萬港元)將用于收購可能與公司現有產能產生協同效應的公司;
5、約10.0%(即50.7百萬港元)將用于營運資金及其他一般企業用途。 |
Underwriting Syndicate
Service Providers
| Role | Institution |
|---|---|
| Legal Advisor to Company |
Clifford Chance 上海澄明则正律师事务所 Pillsbury Winthrop Shaw Pittman LLP |
| Legal Advisor to Sponsors/Underwriters |
欧华律师事务所 金杜律师事务所 |
| Auditor and Reporting Accountant | 德勤•关黄陈方会计师行 |
| Industry Advisor | 弗若斯特沙利文(北京)咨询有限公司上海分公司 |
| Compliance Advisor | Somerley Capital Limited CE BAU754 |
| Receiving Banks | 招商永隆银行有限公司 |
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Costone China Growth Capital I L.P. | 62,240,760 HKD | — | 10.68% | — | 6 months | 2025-06-30 |
| 2 | 达安投资有限公司 | 62,240,760 HKD | — | 10.68% | — | 6 months | 2025-06-30 |
| 3 | 横琴粤澳深度合作区产业投资基金(有限合伙) | 62,240,760 HKD | — | 10.68% | — | 6 months | 2025-06-30 |
| 4 | 星群有限公司 | 27,998,820 HKD | — | 4.81% | — | 6 months | 2025-06-30 |
| 5 | 讯医有限公司 | 61,996,500 HKD | — | 10.64% | — | 6 months | 2025-06-30 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 劉慶峰 | — |
| Company Secretary | 劉偉;楊兆琳 | — |
Major Shareholders
| Major Shareholders & Holdings | 科大訊飛股份有限公司(49.42%),合肥正升信息科技合伙企業(有限合伙)(16.11%),安徽科訊創業投資基金合伙企業(有限合伙)(14.43%) |
|---|
Market Sentiment
The IPO saw tepid retail demand with an oversubscription ratio of just 3.66 times, far below typical Hong Kong market enthusiasm. This resulted in a hit rate of 89.99% (2,822 of 3,136 applications accepted), meaning nearly all applicants received shares. Such high allocation probability signals weak aftermarket sentiment expectations. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
Tier Analysis
An inefficiency appeared at the A/B boundary: the last A-tier application (50,000 lots) expected 1 lot, identical to the first B-tier application (70,000 lots). The extra 20,000 lots in B-head yielded no additional allocation, making A-tail more capital efficient. Broker fee considerations may further favor lower-tier applications, though actual costs vary. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
Demographics
Mainland participants overwhelmingly dominated, comprising 82.4% of the 2,709 holders, highlighting strong domestic recognition for the AI healthcare brand. The investor base skewed male (63.8%) with an average age of 42.2, typical of tech-focused IPOs targeting experienced retail investors. Hong Kong residents accounted for just 17.2% of the total. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)




